These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34240696)

  • 1. Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018/19 influenza season.
    Xu Y; Lewandowski K; Downs LO; Kavanagh J; Hender T; Lumley S; Jeffery K; Foster D; Sanderson ND; Vaughan A; Morgan M; Vipond R; Carroll M; Peto T; Crook D; Walker AS; Matthews PC; Pullan ST
    Euro Surveill; 2021 Jul; 26(27):. PubMed ID: 34240696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.
    Trebbien R; Christiansen CB; Fischer TK
    J Clin Virol; 2018 May; 102():1-6. PubMed ID: 29448067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanopore metagenomic sequencing to investigate nosocomial transmission of human metapneumovirus from a unique genetic group among haematology patients in the United Kingdom.
    Xu Y; Lewandowski K; Jeffery K; Downs LO; Foster D; Sanderson ND; Kavanagh J; Vaughan A; Salvagno C; Vipond R; Carroll M; Danby R; Peto T; Crook D; Walker AS; Matthews PC; Pullan ST
    J Infect; 2020 May; 80(5):571-577. PubMed ID: 32092386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory Samples.
    Lewandowski K; Xu Y; Pullan ST; Lumley SF; Foster D; Sanderson N; Vaughan A; Morgan M; Bright N; Kavanagh J; Vipond R; Carroll M; Marriott AC; Gooch KE; Andersson M; Jeffery K; Peto TEA; Crook DW; Walker AS; Matthews PC
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada.
    Chaudhry A; Bastien N; Li Y; Scott A; Pabbaraju K; Stewart D; Wong S; Drews SJ
    Influenza Other Respir Viruses; 2016 Nov; 10(6):532-535. PubMed ID: 27442795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective surveillance of antiviral resistance in hospitalized infants less than 12 months of age with A(H3N2) influenza infection and treated with oseltamivir.
    Rath B; Chen X; Spies V; Muehlhans S; Obermeier P; Tief F; Seeber L; Karsch K; Milde J; Skopnik H; Schweiger B; Duwe SC
    Antivir Ther; 2017; 22(6):515-522. PubMed ID: 28205506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.
    Hatakeyama S; Sugaya N; Ito M; Yamazaki M; Ichikawa M; Kimura K; Kiso M; Shimizu H; Kawakami C; Koike K; Mitamura K; Kawaoka Y
    JAMA; 2007 Apr; 297(13):1435-42. PubMed ID: 17405969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.
    Tivane A; Daniels R; Nguenha N; Machalele L; Nacoto A; Pale M; Mateonane E; Mavale S; Chilundo J; Muteto D; Salência J; Albati F; Gudo E; Mussá T; McCauley J
    PLoS One; 2018; 13(7):e0201248. PubMed ID: 30048502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterisation of influenza A(H1N1)pdm09 viruses circulating in Assam, Northeast India during 2009-2015.
    Biswas D; Dutta M; Sarmah K; Yadav K; Buragohain M; Sarma K; Borkakoty B
    Indian J Med Microbiol; 2019; 37(1):42-49. PubMed ID: 31424009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012.
    Cai J; Wang X; Zhao B; Yao W; Wang X; Zhu Q; Zeng M
    J Med Virol; 2014 Jun; 86(6):1026-33. PubMed ID: 24523140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular influenza surveillance at a tertiary university hospital during four consecutive seasons (2012-2016) in Catalonia, Spain.
    Andrés C; Peremiquel-Trillas P; Gimferrer L; Piñana M; Codina MG; Rodrigo-Pendás JÁ; Campins-Martí M; Carmen Martín M; Fuentes F; Rubio S; Pumarola T; Antón A
    Vaccine; 2019 Apr; 37(18):2470-2476. PubMed ID: 30926297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015.
    Tewawong N; Vichiwattana P; Korkong S; Klinfueng S; Suntronwong N; Thongmee T; Theamboonlers A; Vongpunsawad S; Poovorawan Y
    PLoS One; 2017; 12(4):e0175655. PubMed ID: 28410396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
    Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
    JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An off-seasonal amantadine-resistant H3N2 influenza outbreak in Japan.
    Saito R; Li D; Shimomura C; Masaki H; Le MQ; Nguyen HL; Nguyen HT; Phan TV; Nguyen TT; Sato M; Suzuki Y; Suzuki H
    Tohoku J Exp Med; 2006 Sep; 210(1):21-7. PubMed ID: 16960341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Resistant and Genetic Evolutionary Analysis of Influenza Virus from Patients During the 2013 and 2014 Influenza Season in Beijing.
    Li X; Liao H; Liu Y; Liu L; Wang F; Song H; Cheng J; Liu X; Xu D
    Microb Drug Resist; 2017 Mar; 23(2):253-260. PubMed ID: 27203354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome Sequencing Provides Data for Stratifying Infection Prevention and Control Management of Nosocomial Influenza A.
    Roy S; Hartley J; Dunn H; Williams R; Williams CA; Breuer J
    Clin Infect Dis; 2019 Oct; 69(10):1649-1656. PubMed ID: 30993315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.